Clinical Trials Directory

Trials / Completed

CompletedNCT02618369

MR-Guided High Intensity Focused Ultrasound for Pain Management Of Osteoid Osteoma & Benign Bone Tumors in Children and Adults

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Pain Management of Osteoid Osteoma and Benign Bone Tumors in Children and Young Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
5 Years – 40 Years
Healthy volunteers
Not accepted

Summary

The Philips Sonalleve HIFU system is expected to be efficacious in reducing pain scores in patients with painful osteoid osteoma and other benign bone tumors, and in reducing their pain medication usage. No serious adverse effects are expected to result from this treatment.

Detailed description

The objective of this study is to determine if MR-guided high-intensity focused ultrasound (MR-HIFU) is safe and effective technique for alleviating the pain associated with osteoid osteoma and other benign bone tumors in paediatric patients and adults(up to age 40 yrs). This technique meant to be an alternative to the standard-of-care, radiofrequency and laser-based percutaneous ablation. Safety of the technique will be assessed through evaluating non-targeted heating using MRI based temperature mapping. and inspecting patients post treatment for skin burns or other signs of serious adverse events. Efficacy of the technique will be assessed by evaluating/recording patients observed pain, quality of life, and pain medication usage both before and up to 6 months following treatment.

Conditions

Interventions

TypeNameDescription
DEVICEMR-Guided High Intensity Focused UltrasoundTarget treatment of bone lesion using High Intensity Focused Ultrasound

Timeline

Start date
2014-04-01
Primary completion
2018-04-01
Completion
2018-10-01
First posted
2015-12-01
Last updated
2024-05-03

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02618369. Inclusion in this directory is not an endorsement.